We carry the generic forms of Ozempic (semaglutide) and Mounjaro (tirzepatide). These are generic, compounded forms made in a 503B United States pharmacy. These medications are delivered to your body in weekly subcutaneous injections done either at home by you, or in our office by our staff. GLP-1 peptides suppress hunger, slow down the emptying of the stomach to induce a feeling of fullness faster and for longer periods, regulate insulin release, and enhance glucagon storage.Tirzepatide, a novel medication for obesity treatment, acts as an agonist for both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. It combines the effects of these natural incretin hormones, resulting in decreased food intake, increased calorie expenditure, and weight loss. When used alongside a GLP-1 receptor agonist, it produces even more significant impacts on glucose levels and body weight.The combined action of these compounds leads to significant reductions in A1C levels, enhanced weight loss, improvements in cardiometabolic parameters, and decreased appetite.